Vertex Pharmaceuticals Incorporated
2019 Estimated Media Spend: $******
2019 Revenue: $4,162,800,000.00
Headquartered in Cambridge, MA, Vertex Pharmaceuticals Incorporated is a biotechnology company in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Telaprevir, a leading drug candidate, is an oral hepatitis C protease inhibitor and one of the most advanced of a new class of antiviral treatments in clinical development that target hepatitis C virus (HCV), infection.